Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Vanos Articles

Perrigo confirms filing for generic Vanos

16 June 2008

Broader indication for Medicis' Vanos

13 March 2006

Fujisawa makes strategic drug transfers ahead of merger

28 February 2005

Medicis psoriasis drug given FDA clearance

21 February 2005

Canada accuses GSK, Roche of tax dodging

10 July 2001

FDA clears Taro's fluocinomide

16 July 1999

Bioglan deal with Allergan on Zorac

20 April 1999

Bioglan Buys Zeneca Dermatology Products

12 August 1998

Tazarotene - 1st Effective Topical Retinoid For Psoriasis?

18 September 1997

Taro And Mylan Gain FDA Approvals

13 January 1997

A L Pharma gets US approval for Fluocinonide cream USP

3 July 1995

TEVA AND DU PONT MERCK SALES DEAL

12 October 1992

TEVA TO SIGN ACQUISITION DEAL

7 September 1992

POSITIVE FORECAST FOR GENTA'S TECHNOLOGY

18 May 1992

TEVA PHARMA NET INCOME UP 25%

9 March 1992

TEVA GENERIC APPROVED IN USA

20 January 1992

Showing 1-16 of 16 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Australia's pharma industry applauds R&D regulatory reform
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Australia's pharma industry applauds R&D regulatory reform

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS